Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
threat decrease » greater decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
threat decrease » greater decrease (Expand Search)
-
3561
-
3562
Frequency distribution of SOLEC at baseline and follow-ups in WAD grade 2 and WAD grade 3.
Published 2024Subjects: -
3563
-
3564
-
3565
Line graph showing the values of inflammatory cytokines at baseline and after treatment.
Published 2025Subjects: -
3566
Baseline descriptive characteristics of trial participants (n = 140) with and without dizziness.
Published 2024Subjects: -
3567
-
3568
-
3569
-
3570
Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups.
Published 2024Subjects: -
3571
-
3572
Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.
Published 2025Subjects: -
3573
-
3574
-
3575
Baseline descriptive characteristics of trial participants with dizziness, by treatment group.
Published 2024Subjects: -
3576
-
3577
Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.
Published 2025Subjects: -
3578
-
3579
Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.
Published 2025Subjects: -
3580
Variables obtained from the SF-36 quality of life questionnaire in each experimental group.
Published 2025Subjects: